Life Stem Genetics Inc.
LIFS
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.58K
Close$
Share Statistics
| Market cap | $4,584.00 |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 0 |
| Outstanding Shares | 245,837,500 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -2.53 |
|---|---|
| PEG | 3.7 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Life Stem Genetics Inc.
0
CEO: Gloria Simov Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical...